Allergic contact dermatitis from pharmaceutical grade BHA in Timodine, with no patch test reaction to analytical grade BHA.
Orton
D I
DI
Department of Dermatology, Amersham Hospital, UK.
Shaw
S
S
D000287:Administration, Topical; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000935:Antifungal Agents / Q000009:adverse effects*; D001548:Benzalkonium Compounds / Q000009:adverse effects*; D002083:Butylated Hydroxyanisole / Q000009:adverse effects* / Q000737:chemistry; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis* / Q000209:etiology; D004338:Drug Combinations; D004339:Drug Compounding; D005260:Female; D006801:Humans; D006854:Hydrocortisone; D008297:Male; D008875:Middle Aged; D009761:Nystatin / Q000009:adverse effects*; D010328:Patch Tests; D012841:Simethicone / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D001548:Benzalkonium Compounds; D004338:Drug Combinations; D009761:Nystatin; D002083:Butylated Hydroxyanisole; D012841:Simethicone; C041602:Timodine; D006854:Hydrocortisone